UnitedHealth 因声称在 Change Healthcare 交易后在数据防火墙保护方面误导投资者而面临调查，导致股价下跌 $25B。 UnitedHealth faces probe over claims it misled investors on data firewall protections post-Change Healthcare deal, spurring a $25B stock drop.

United Health Group正接受一家律师事务所的调查, 指控该公司在美国司法部于2024年2月重新启用反托拉斯探测器后, 误导投资者在Optum和United Health Careurity两个单位之间保护数据防火墙。 UnitedHealth Group is under investigation by a law firm over allegations it misled investors about data firewall protections between its Optum and UnitedHealthcare units after acquiring Change Healthcare, following a U.S. Department of Justice antitrust probe reopening in February 2024. 在司法部重新审查后,股票每股下跌27美元,价值损失近250亿美元。 The stock dropped $27 per share, losing nearly $25 billion in value, after the DOJ’s renewed scrutiny. 尽管第二季度报告每股收入为4.08美元,低于4.45美元的估计数,年同比收入增长12.9%,增至111.62亿美元,但该公司重申其2025年的收入准则,即每股16美元。 Despite reporting second-quarter earnings of $4.08 per share—below the $4.45 estimate and a 12.9% year-over-year revenue increase to $111.62 billion—the company reaffirmed its 2025 earnings guidance at $16.00 per share. 分析师维持协商一致的“等待”评级,目标为365美元,而机构所有权仍然强劲,达到87.86%。 Analysts maintain a consensus "Hold" rating with a $365 target, while institutional ownership remains strong at 87.86%.